Literature DB >> 11402589

Peyronie's disease.

S S Gholami1, T F Lue.   

Abstract

Peyronie's disease remains one of the most perplexing diseases in urology. With continued basic research in wound healing and scarring, the understanding and management of this frustrating disease will improve. Initial treatment of Peyronie's disease should be conservative, with expectant therapy and medical management. Once the penile curvature and plaque have stabilized, patients with severe deformity can be offered surgery depending on their symptoms and complaints. Patient selection is the key to proper treatment. Less experienced surgeons should limit themselves to medical management or simple surgical management of the disease, including plication or Nesbit procedures. Penile-lengthening procedures or the placement of complicated penile prosthesis should be reserved for surgeons with familiarity and expertise in this type of reconstruction. Education on the pathogenesis and natural history of the disease will allow the patient and his partner to make an informed decision in regards to treatment options and expected outcomes.

Entities:  

Mesh:

Year:  2001        PMID: 11402589     DOI: 10.1016/s0094-0143(05)70146-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

Review 1.  Peyronie's surgery: graft choices and outcomes.

Authors:  Aaron C Lentz; Culley C Carson
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

2.  Microsurgical tunica albuginea transplantation in an animal model.

Authors:  Salvatore Sansalone; Carla Loreto; Rosario Leonardi; Giuseppe Vespasiani; Giuseppe Musumeci; Claudia Lombardo; Sergio Castorina; Venera Cardile; Rosario Caltabiano
Journal:  Asian J Androl       Date:  2017 Nov-Dec       Impact factor: 3.285

3.  The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease.

Authors:  Carla Loreto; Giampiero La Rocca; Rita Anzalone; Rosario Caltabiano; Giuseppe Vespasiani; Sergio Castorina; David J Ralph; Selim Cellek; Giuseppe Musumeci; Salvatore Giunta; Rados Djinovic; Dragoslav Basic; Salvatore Sansalone
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.